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Abstract
The Chuvash form of polycythemia is an autosomal recessive disorder common to a large number of families in central Russia. Affected individuals have been reported to be homozygous for an Arg200Trp mutation in the von Hippel-Lindau (VHL) gene.
We have screened 78 patients with erythrocytosis and found eight of Bangladeshi and Pakistani origin to be homozygous for the Arg200Trp mutation and another of English descent to be heterozygous. Five of these patients have elevated serum erythropoietin (Epo) levels, while the other four have Epo values in the normal range.
The heterozygous patient does not fulfil the Chuvash criterion for homozygosity of Arg200Trp mutation and consequently may harbor a further, as yet uncharacterized mutation. This mutation has a wider geographical distribution than originally presumed and haplotype analysis suggests a common origin of the Arg200Trp mutation in the four families but it still remains to be established if it has arisen independently of the Chuvash population.
Introduction
The autosomal recessive disorder known as the Chuvash form of familial polycythemia affects over 100 individuals from more than 80 families in the midVolga Region of European Russia. 1 It is characterized by high hemoglobin levels, usually more than 20 g/dL, and normal to raised plasma erythropoietin (Epo Epo production is tightly regulated by a negative feedback loop 5 involving the transcription complex HIF-1. 6 This complex is composed of two subunits, HIF-1 and the constitutively stable HIF-1 (also known as ARNT). 7 Under normoxia the level of HIF-1 is maintained at a low level as it binds to the VHL protein, becomes ubiquitinated and is targeted by the elongin C complex for degradation by the proteasome. 8 A point mutation in the VHL gene is known to disrupt its association with HIF-1 and increase Epo production. 9 Thus we decided to screen for VHL mutations in a group of erythrocytosis patients with normal to raised Epo levels, who were negative for Epo receptor (EpoR) mutations.
Study Design

Patients and Case History
Idiopathic erythrocytosis patients from the UK and Ireland with elevated hemoglobin (Hb) (greater than 18 g/dL in males and 16.5 g/dL in females), raised packed cell presented with hemoglobin of 16.7 g/dL and PCV of 0.67 with no history of stroke and so had no cerebrovascular investigation. Both B2 and B3 were iron deficient. Epo levels for B1-B3 were 369 mU/ml, 128 mU/ml and 105 mU/ml (NR 2.5-10.5 mU/ml) 
Results and Discussion
A group of 46 patients with raised and normal Epo levels were chosen from our registry of erythrocytosis patients. Sequencing all three exons of the VHL gene detected a homozygous C to T transition at nucleotide 598 in 4 siblings of family A (Figure 2A ), 3 siblings from Family B and patient C1. A ninth patient (D1) was found to be heterozygous for this mutation ( Figure 2C ). The C598T mutation destroys the restriction site for BsrB 1 enzyme and a further group of 32 erythrocytosis patients with low to normal Epo levels were screened for the C598T mutation and found to be negative.
The C598T mutation predicts an amino acid change of arginine to tryptophan at codon 200 (Arg200Trp), which is located outside the seven-stranded domain of pVHL that binds HIF-1 (residues 63 to 154), but lies within the helix (residues 193-204). 10 Although this helix does not bind directly to HIF-1 it may contribute to the association of VHL and HIF-1 . 10 The Arg200Trp mutation affects the affinity of pVHL for HIF-1 thereby prolonging the stability of HIF-1 and upregulating Epo production.
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For Figure 2 . Detection of C598T mutation. Sequencing of exon 3 of the VHL gene detected a homozygous base change of C to T at nucleotide 598 in patients A1-A3, B1-B3 and C1 (Figure 2A ) when compared to the normal sequence ( Figure 2B ). One patient, D1, was heterozygous for this base change ( Figure 2C ). The position of the mutation is indicated by an arrow. The C598T mutation destroys the restriction site for BsrB 1 enzyme and the normal exon 3 PCR product is restricted into 2 fragments of 330 and 132 bp but in the presence of the C598T mutation only a 462 bp fragment is obtained. Screening of family members of C1 indicated that his mother was heterozygous and his sibling was normal ( Figure 2D ). The father of D1 is normal but his mother and son are heterozygous for the C598T ( Figure 2E A common haplotype of GCTACA was found to be associated with the Arg200Trp mutation ( Table 2 ) thus suggesting a founder mutation in our group of patients. A comprehensive haplotype analysis of individuals from Chuvashia and the other ethnic groups will establish if there was a common founder mutation that has been distributed by migration.
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